leadf
logo-loader

Pharma & Biotech

Add to MyProactive
Health

Amplia Therapeutics details upcoming Phase 2 pancreatic cancer trial

Amplia Therapeutics to conduct Phase 2 trial for its Focal Adhesion Kinase inhibitor AMP945 in first line pancreatic cancer patients Health Amplia Therapeutics to conduct Phase 2 trial for Focal Adhesion...
4 days, 16 hours ago
Emyria Ltd - Emyria expands psychiatry advisory with new appointment Health Emyria expands psychiatry advisory team with new appointment
4 days, 18 hours ago
Chimeric Therapeutics Ltd - Chimeric Therapeutics appoints experts to Cellular Immunotherapy Scientific Advisory Board Health Chimeric Therapeutics appoints experts to Cellular Immunotherapy...
5 days, 15 hours ago
Orthocell Ltd - Orthocell explores new application for CelGro® platform in ACL injuries Health Orthocell explores new application for CelGro® platform in ACL...
5 days, 17 hours ago
Volpara Health Technologies Ltd - Volpara Health Technologies with Proactive at the ASX Small and Mid Cap Conference
6 days, 14 hours ago
Immutep Ltd - Immutep with Proactive at the ASX Small and Mid Cap Conference
6 days, 14 hours ago
Kazia Therapeutics Ltd - Kazia Therapeutics with Proactive at the ASX Small and Mid Cap Conference
6 days, 18 hours ago
Nyrada - Nyrada Inc with Proactive at the ASX Small and Mid Cap Conference
6 days, 19 hours ago
Chimeric Therapeutics Ltd - Chimeric Therapeutics with Proactive at the ASX Small and Mid Cap Conference
6 days, 20 hours ago
Noxopharm Ltd - Noxopharm looks ahead to an even more highly productive FY22 with clear therapeutic and commercial strategies
1 week, 1 day ago
Paradigm Biopharmaceuticals Ltd - Paradigm Biopharmaceutical highlights study supporting arthritic disease modifying effects of PPS in Chikungunya virus published in PLoS ONE journal
1 week, 1 day ago
Rhinomed Ltd - Rhinomed higher on initial Victorian Government order for a million Rhinoswabs to accelerate SARS-CoV-2 testing
1 week, 4 days ago
Paradigm Biopharmaceuticals Ltd - Investing in a biotech company? Here’s what you need to know
1 week, 6 days ago
Wellnex Life Ltd - Wellnex Life reports record revenue growth of 49% in July and August
2 weeks ago
Little Green Pharma Ltd - Little Green Pharma expands into psychedelics, receives WA Schedule 9 licence
2 weeks ago
Orthocell Ltd - Orthocell secures new patents for CelGro® suture-less repair of soft tissue
2 weeks ago
Australian Strategic Materials Ltd - Australian Strategic Materials and Imugene added to S&P/ASX 300 index in rebalance
2 weeks ago
Anteris Technologies Ltd - Anteris Technologies appoints highly experienced Chief Medical Officer
2 weeks, 1 day ago
Imugene Ltd upgraded to Buy and target price boosted to 52 cents by Bell Porter on the back its capital raise and three new HER vaxx trials
2 weeks, 4 days ago